Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
17.2%
% of IBB's 212 holdings also in CANC
70.2%
% of CANC's 47 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 9.7% | 5.4% | 5.4% |
|
REGENERON PHARMACEUTICALS | 5.2% | 5.4% | 5.2% |
 |
ARGENX SE ADR | 3.1% | 4.3% | 3.1% |
|
ILLUMINA INC | 2.2% | 3.8% | 2.2% |
|
BEIGENE LTD. SPONSORED ADR | 1.7% | 2.5% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to CANC
|
VERTEX PHARMACEUTICALS INC | 7.8% |
|
AMGEN INC | 5.6% |
|
GILEAD SCIENCES INC | 4.3% |
|
IQVIA HOLDINGS INC | 3.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
BIOGEN IDEC INC | 2.3% |
|
WATERS CORP | 2.2% |
|
NATERA INC | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.6% |
IBB Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.2% |
|
REVOLUTION MEDICINES, INC. | -3.8% |
|
BLUEPRINT MEDICINES CORP. | -3.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
MERCK & CO. INC. | -2.9% |
|
INCYTE CORP | -2.8% |
|
AGIOS PHARMACEUTICALS INC | -2.5% |
|
GUARDANT HEALTH, INC. | -2.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |